Susquehanna Fundamental Investments’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
GKIM
ACH
HRCM
SIMG
PIM
Susquehanna Fundamental Investments's TNDM Position: Q1 2025 in Review
Susquehanna Fundamental Investments sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 51,703 shares — an estimated $1.86M sold.
Susquehanna Fundamental Investments first reported a position in TNDM in Q2 2020 and held it in 12 quarters. The position peaked at $9.28M in Q1 2022. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.
- Susquehanna Fundamental Investments reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
- Susquehanna Fundamental Investments sold 51,703 Tandem Diabetes Care shares in Q1 2025, an estimated $1.86M.
- Susquehanna Fundamental Investments first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 12 quarters.
- Susquehanna Fundamental Investments's Tandem Diabetes Care position peaked at $9.28M in Q1 2022.
- 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.
Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.